Region: Global
Category: Oncology/Hematology

Global Oncology/Hematology

(1,182 reports matching your criteria)
  • The 2025-2030 World Outlook for Neuroendocrine Carcinoma

    ... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More

  • The 2025-2030 World Outlook for Immunotherapy Cancer Drugs

    ... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More

  • The 2025-2030 World Outlook for Precision Cancer Diagnostics

    ... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More

  • The 2025-2030 World Outlook for Gastric Cancer Monoclonal Antibodies (mAb)

    ... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More

  • The 2025-2030 World Outlook for Cancer Profiling Technologies

    ... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More

  • The 2025-2030 World Outlook for Cancer Therapies

    ... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More

  • The 2025-2030 World Outlook for Liver Cancer Drugs

    ... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More

  • The 2025-2030 World Outlook for Kidney Cancer Drugs

    ... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More

  • The 2025-2030 World Outlook for Checkpoint Inhibitors for Anti-Cancer Treatments

    ... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More

  • The 2025-2030 World Outlook for Cervical Cancer Diagnostics

    ... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More

  • The 2025-2030 World Outlook for Cervical Cancer Drugs and Diagnostics

    ... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More

  • The 2025-2030 World Outlook for Multiple Myeloma Treatments

    ... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More

  • The 2025-2030 World Outlook for Prostate Cancer Treatments and Prevention

    ... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More

  • The 2025-2030 World Outlook for In-Vitro Colorectal Cancer Screening Tests

    ... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More

  • The 2025-2030 World Outlook for Cancer Supportive Care Therapeutics

    ... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More

  • The 2025-2030 World Outlook for Cancer Vaccines

    ... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More

  • The 2025-2030 World Outlook for Cancer-Treating Drugs

    ... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More

  • The 2025-2030 World Outlook for Pancreatic Cancer Treatments

    ... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More

  • The 2025-2030 World Outlook for Pancreatic Cancers

    ... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More

  • The 2025-2030 World Outlook for Veterinary Hematology Table Top Analyzers

    ... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More

  • The 2025-2030 World Outlook for Cancer Immunotherapy Drug Discovery Outsourcing

    ... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More

  • The 2025-2030 World Outlook for Breast Cancer Treatments

    ... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More

  • The 2025-2030 World Outlook for Breast Cancer Drugs

    ... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More

  • The 2025-2030 World Outlook for Hematological Cancer Treatments

    ... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More

  • The 2025-2030 World Outlook for Squamous Cell Carcinoma of the Head and Neck Treatments

    ... For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, ... Read More

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings